Vaxcyte has had a massive rally in its shares since late October. What next for this vaccine concern? Find out what investors need to know about PCVX stock.
BridgeBio Pharma's stock fell at the end of 2021 on some disappointing trial results. Read whether late-stage candidates and collaboration deals make BBIO a Buy.